Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07080359

Isavuconazole in Critically Ill Patients: Efficacy and Safety

Sponsor: Shanghai 10th People's Hospital

View on ClinicalTrials.gov

Summary

Due to factors such as disease status, gastrointestinal conditions, commonly used medications (e.g., vasopressors), and cardiac output, the plasma concentration of isavuconazole in critically ill patients may differ from that in healthy individuals, exhibiting significant variability. This study aims to explore the variability of isavuconazole plasma concentrations in critically ill patients and its correlation with efficacy and adverse effects. The research includes: 1. The distribution and variability of isavuconazole plasma concentrations in critically ill patients; 2. Clinical outcomes; 3. Adverse effects.

Official title: Isavuconazole in Critically Ill Patients: A Study on Antifungal Efficacy and Safety

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

75

Start Date

2025-08-01

Completion Date

2030-12-31

Last Updated

2025-07-23

Healthy Volunteers

No

Interventions

DRUG

Isavuconazole treatment

Administer isavuconazole as follows: Loading dose: 200 mg every 8 hours (q8h) for three times, Maintenance dose: 200 mg once daily (qd)